Document is current
Any future updates will be listed below
-
Authors
Akcan Arikan, Ayse
Ostermann, Marlies https://orcid.org/0000-0001-9500-9080
Goldstein, Stuart L.
Kellum, John A. https://orcid.org/0000-0003-1995-2653
- License Information
-
More Information
Article History
Accepted: 22 May 2025
First Online: 12 June 2025
Competing interests
: A.A.A has received institutional research funding from Bioporto, Medtronic and Baxter and serves on the scientific advisory boards of SeaStar Medical, CSLVifor and Mallinckrodt. M.O. has received institutional research funding from BioMérieux and Baxter. S.L.G. discloses consulting fees from Baxter, Mozarc Medical, NuWellis, BioPorto, SeaStar Medical, Novartis, Talphera, Silver Creek, Calcimedica, Fresenius and Otsuka, has received grant support from BioPorto, SeaStar Medical, ExThera, Talphera, Mozarc Medical and Baxter and has equity interest in MediBeacon. J.A.K. has received consulting fees from BioMérieux, AstraZeneca, Bayer, Novartis, Mitsubishi Tenabe and Chugai Pharma, and is Chief Medical Officer of and holds stock with Spectral Medical.
